 |
|
Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients
Da Hea Seo, Yongin Cho, Sujin Lee, Seho Park, Seung-Il Kim, Byeong Woo Park, Yumie Rhee
Korean J Intern Med. 2019;34(3):579-587. Published online 2017 Aug 25 DOI: https://doi.org/10.3904/kjim.2016.205
|
|
Citations to this article as recorded by
 Impact of Aromatase Inhibitors Treatment Duration on Coronary Artery Calcification in Postoperative Patients With Breast Cancer
Yu Hiasa, Akinori Higaki, Yoshiaki Kamei, Tomoaki Nishikawa, Ryo Miyabe, Tomoki Fujisawa, Shigehiro Miyazaki, Yusuke Akazawa, Toru Miyoshi, Hiroshi Kawakami, Fumiyasu Seike, Haruhiko Higashi, Shunsuke Tamaki, Kazuhisa Nishimura, Katsuji Inoue, Shuntaro Ik
Canadian Journal of Cardiology.2024; 40(11): 2224. CrossRef Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors
Annemiek van Ommen-Nijhof, Judy N. Jacobse, Lars C. Steggink, Joop D. Lefrandt, Jourik A. Gietema, Flora E. van Leeuwen, Michael Schaapveld, Gabe S. Sonke
Breast Cancer Research and Treatment.2022; 196(3): 591. CrossRef Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion
Vincent Koppelmans, Kimberly D. van der Willik, Berthe M. P. Aleman, Flora E. van Leeuwen, Maryam Kavousi, Banafsheh Arshi, Meike W. Vernooij, M. Arfan Ikram, Sanne B. Schagen
Breast Cancer Research and Treatment.2021; 186(1): 167. CrossRef
|